03. Synthetic Cannabinoids: Epidemiology, Clinical Manifestations, and Practical Diagnostic Aspects

Learning Objectives:

After completing this activity, the learner will be able to:

1. Recognize the clinical manifestations and potential complications of designer drugs.
2. Apply treatment strategies to manage intoxication or withdrawal from designer drugs.

Original Release Date: 12/17/2018

Expiration Date: 03/31/2022

Relevant Financial Disclosures:

None of the faculty, planners, and reviewers for this educational activity have relevant financial relationships to disclose during the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com